Literature DB >> 35915687

COVID-19 Vaccine-Induced Cerebral Sinus Thrombosis: Coincidence vs. Cause?

Abdalla Fadul1, ELMustafa Abdalla1, Elabbass Abdelmahmuod1, Mohammed Abdulgayoom2, Elrazi Ali1, Akram Al-Warqi3, Hani Al-Yahary1.   

Abstract

Patients who were vaccinated against COVID-19 have experienced thrombosis-thrombocytopenia syndrome and cerebral venous sinus thrombosis (CVST). It is important to be aware of this potential side effect of the vaccine and to be able to recognize early clinical symptoms and signs of CVST. In this paper, we present two cases of COVID-19 vaccination-related CVST. The patients who suffered headaches and seizures were found to have CVST, which was treated with anticoagulation.
Copyright © 2022, Fadul et al.

Entities:  

Keywords:  cerebral venous sinus thrombosis (cvst); covid 19; covid-19 vaccine; moderna vaccine; thrombosis

Year:  2022        PMID： 35915687      PMCID： PMC9337791          DOI： 10.7759/cureus.26436

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  14 in total

1.  US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.

Authors:  Isaac See; John R Su; Allison Lale; Emily Jane Woo; Alice Y Guh; Tom T Shimabukuro; Michael B Streiff; Agam K Rao; Allison P Wheeler; Suzanne F Beavers; Anna P Durbin; Kathryn Edwards; Elaine Miller; Theresa A Harrington; Adamma Mba-Jonas; Narayan Nair; Duong T Nguyen; Kawsar R Talaat; Victor C Urrutia; Shannon C Walker; C Buddy Creech; Thomas A Clark; Frank DeStefano; Karen R Broder
Journal:  JAMA       Date:  2021-06-22       Impact factor: 56.272

2.  COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Authors:  S A Meo; I A Bukhari; J Akram; A S Meo; D C Klonoff
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

3.  Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.

Authors:  Usama Waqar; Shaheer Ahmed; Syed M H Ali Gardezi; Muhammad Sarmad Tahir; Zain Ul Abidin; Ali Hussain; Natasha Ali; Syed Faisal Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program.

Authors:  Tinevimbo Shiri; Marc Evans; Carla A Talarico; Angharad R Morgan; Maaz Mussad; Philip O Buck; Phil McEwan; William David Strain
Journal:  Vaccines (Basel)       Date:  2022-01-18

Review 5.  A review of the safety and efficacy of current COVID-19 vaccines.

Authors:  Zehong Huang; Yingying Su; Tianying Zhang; Ningshao Xia
Journal:  Front Med       Date:  2022-02-03       Impact factor: 9.927

Review 6.  Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.

Authors:  Brit Long; Rachel Bridwell; Michael Gottlieb
Journal:  Am J Emerg Med       Date:  2021-05-25       Impact factor: 4.093

7.  Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature.

Authors:  Katarina Dakay; Jared Cooper; Jessica Bloomfield; Philip Overby; Stephan A Mayer; Rolla Nuoman; Ramandeep Sahni; Edwin Gulko; Gurmeen Kaur; Justin Santarelli; Chirag D Gandhi; Fawaz Al-Mufti
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-11-06       Impact factor: 2.136

8.  A case report of cerebral venous infarction due to venous sinus thrombosis as complication in a Covid-19 patient.

Authors:  Dr Abdul Qadir Qader; Dr Omid Nahzat; Dr Adelah Junaidy Qader; Dr Samira Atahi
Journal:  Radiol Case Rep       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.